Maternal transport of immunoglobulin to the newborn mammal is important for immune defense during the first weeks of independent life. Receptors for the Fc portion of IgG mediate the transfer of immunoglobulin from milk to the bloodstream of newborn mice and rats, by passage through intestinal epithelial cells. Neonatal Fc receptors (FcRn) isolated from intestinal epithelial cells of suckling rats bear a striking resemblance to class I histocompatibility molecules. The heavy chain of FcRn has sequence similarity in three extracellular domains to the corresponding domains of class I molecules, and the light chain of both types of molecules is (12-microglobulin.
soluble FcRn appear similar to spectra of class I MHC molecules, suggesting that the similarities in primary sequence extend also to a similarity in secondary structure. Soluble FcRn crystallizes in a form amenable to a structure determination by x-ray diffraction methods, which will ultimately allow a detailed comparison of the two types of molecules.
Newborn rats acquire humoral immunity through ingestion of milk containing maternal IgG. Fc receptors on the intestinal epithelial cells of the neonate (FcRn) bind IgG from milk at acidic pH (6.0-6.5) and transport it to the basolateral membrane at the serosal side of the cell, where the IgG dissociates at a pH of 7.4. FcRn has been affinity-purified from rat intestinal epithelial cell brush borders and shown to be a heterodimer consisting of two polypeptide chains of relative molecular masses 45,000-53,000 (p51) and 14,000 (p14) (1) .
The light chain is P2-microglobulin (f32m), a soluble protein also found complexed to the heavy chains of class I major histocompatibility complex (MHC) molecules. The similarity between FcRn and histocompatibility molecules also extends to the p5i subunit, which consists of three extracellular domains, all with sequence similarity to the corresponding domains of class I MHC proteins, and an unrelated cytoplasmic domain (2, 3) . Class I MHC molecules bind short peptides derived from intracellular proteins, which are transported along with the MHC molecule to the cell surface, and stable cell surface expression appears to depend upon peptide binding (4) (5) (6) (7) . Crystallographic analyses of the peptide binding sites of three human class I MHC molecules have revealed extra electron density presumably corresponding to images of bound endogenous peptides (8) (9) (10) . It would be of interest to determine whether the structurally related FcRn molecule is also transported to the cell surface with endogenous peptide(s) and whether FcRn requires a bound peptide for structural stability.
Here we report the expression of two different lipid-linked forms and one secreted form of FcRn in a glutamine synthetase-based amplifiable expression system developed at Celltech, Berkshire, U.K. (11) . Both lipid-linked forms reproduce the physiological pH dependence of Fc binding and can be released as soluble molecules from the membrane with phosphatidylinositol-specific phospholipase C (PI-PLC). Soluble FcRn can be purified from cell supernatants by affinity chromatography on a rat IgG column at pH 6. (12) . The p51-DAF and f32m-DAF chimeras were constructed by methods similar to those used for the expression of a lipid-linked form of the T-cell antigen receptor (13) . The chimeric proteins consisted of the phosphatidylinositol (PI)-anchoring signal of decay-accelerating factor (DAF; residues 311-347; ref. 14) fused C-terminal to amino acid 269 of the FcRn heavy chain or to the final amino acid of P2m. Briefly, a BamHI fragment containing the full-length FcRn (2) or rat (32m cDNA (N.E.S., unpublished data) was inserted 5' to the DNA segment encoding the DAF PI-anchoring signal (14) cloned in pBluescript SK(-) (Stratagene). Oligonucleotide-directed in vitro deletional mutagenesis (15) generated an Abbreviations: FcRn, neonatal Fc receptor(s); f32m, /32-microglobulin; MHC, major histocompatibility complex; PI-PLC, phosphatidylinositol-specific phospholipase C; DAF, decay-accelerating factor; MSX, methionine sulfoximine. §To whom reprint requests should be addressed.
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in-frame fusion between the FcRn heavy chain (p51-DAF) or (32m (132m-DAF) and the PI-anchoring signal. Truncated FcRn heavy chain was created by inserting a stop codon after amino acid 269 (p51-stop) (Fig. 1A) . (pH 8.0). The percent helix, p-strand, and disordered structure (random) was estimated by fitting the spectra to reference data (18) with a nonrestrained least-squares algorithm (19) .
Crystallization of Soluble FcRn. Crystals were grown by vapor diffusion from protein solutions (20 mg/ml) in 10 mM Pipes, pH 6.5/0.05% NaN3, in 2-,ul droplets with 24.0%o (wt/vol) polyethylene glycol 3350, 2.0% (wt/vol) saturated ammonium sulfate, and 100 mM Pipes (pH 6.5).
RESULTS
Expression of Two Lipid-Linked Forms of FcRn. An expression vector (Fig. 1B) containing the hamster glutamine synthetase gene (11) (for selection and amplification), the gene encoding the extracellular portion of the FcRn heavy chain fused in-frame to the cDNA from DAF encoding its lipid attachment signal (14) , and the rat r2m gene was transfected into CHO cells. Stable lines were generated and the transfected gene was amplified by selection with MSX. Cell surface expression of FcRn heavy and light chains was detected by immunostaining with anti-p5i and anti-rat f32m antibodies and was reduced after treatment with PI-PLC (Fig.   2 B) (Fig. 2D4) .
The second lipid-linked form of FcRn was expressed by transfecting a plasmid containing the DNA encoding the DAF PI-attachment signal (14) fused to the rat r2m gene, together with the gene encoding the FcRn heavy chain truncated with an in-frame stop codon after amino acid 269 (p51-stop), and the glutamine synthetase gene (Fig. 1B) . Stable f32m antibodies. Staining was reduced after treatment with PI-PLC (Fig. 2 Cl and C2) . The FcRn/f82m-DAF heterodimers also showed the expected pH dependence of Fc binding (Fig. 2D3) . Expression levels of the two forms of lipid-linked FcRn heterodimers appeared comparable (Fig. 2  B) and Cl). Expression of Secreted FcRn. An expression vector (Fig.  1B) containing the glutamine synthetase gene, the truncated FcRn heavy chain gene, and the rat P2m gene was transfected into CHO cells. Media collected from individual clones were assayed for secretion of FcRn heterodimers by Western blotting aliquots of supernatants with antibodies specific for the heavy and light chains. Positive clones were amplified with increasing amounts of MSX. Medium (250 ml) from a high-expressing clone growing in 100 ILM MSX was adjusted to pH 6.5 and passed over a rat IgG affinity column. The column was extensively washed, and FcRn heterodimers were eluted by changing the pH to 8.0, yielding -10 mg of purified protein. The high-expressing CHO clone was grown in a Cell Pharm II hollow-fiber bioreactor device (Unisyn Fibertec, San Diego) in the presence of 100 IiM MSX. The yield of soluble FcRn was typically 7-10 mg per daily harvest.
Purified FcRn was analyzed by SDS/17.5% PAGE (Fig. 3 ). Under either reducing or nonreducing conditions, two bands were detected: a sharp band of apparent molecular mass 13 kDa, corresponding to ,82m, and a broad diffuse band at -43 kDa, corresponding to the truncated FcRn heavy chain. Treatment of purified FcRn with a mixture of endoglycosidase F and N-glycosidase F had no effect on the apparent molecular mass of h2m, but the majority of the heavy chain shifted its position of migration to 30 kDa, in close agreement with the predicted molecular mass of the unmodified truncated heavy chain (30,274 daltons). Glycosidase-treated FcRn did not bind to a lentil lectin column (data not shown), also suggesting that all carbohydrate moieties were removed. These data suggest that =13 kDa of the extra molecular mass was due to N-linked glycosides, a figure that is not inconsistent with the utilization of all four potential N-linked glycosylation sites in the FcRn heavy chain sequence (2 Immunology: Gastinel et al. carbohydrate moieties were not involved in the interaction between FcRn and Fc.
Purified soluble FcRn was subjected to N-terminal sequence analysis to verify the origin of the (32m species associated with the FcRn heavy chain and to look for possible peptides associated with the FcRn heavy chain. Since the sequence of hamster 82m was previously unknown, a cDNA library was constructed from CHO cell RNA, and a hamster f32m clone was isolated and sequenced (L.N.G., unpublished data; EMBL data library, accession no. X57112). The first 16 residues of bovine (20) and rat (21) (32m differ at amino acid residues 3, 4, and 6 (ofthe mature protein), and the sequences of hamster and rat ,32m differ at residues 3, 4, 7, and 11. Two N-terminal sequences in equimolar amounts were identified in the FcRn sample: the sequence AEPRLPLMYH-LAAVSD, corresponding to the first 16 amino acids of the mature FcRn heavy chain (3), and the sequence IQKTP-QIQVYSRHPPE, corresponding to the sequence of the first 16 residues of mature rat 32m (21) . No evidence of sequences corresponding to bound peptides was seen.
CD Spectral Comparison of Soluble FcRn and MHC Class I Proteins. Analysis of CD spectra of HLA-B40 and soluble FcRn (Fig. 4) by a nonrestrained least squares fitting procedure indicated a dominant B-strand component with a minor helical contribution, similar to that reported previously (22, 23) for HLA-B7 and HLA-A2, although lower amounts of p-structure were predicted for other class I MHC molecules from CD spectral analyses (23, 24) . The percent helix estimated from our analysis of the spectrum of HLA-B40 agrees well with the amount found in class I MHC crystal structures (8-10) (-20% helix), but our CD analysis predicts a higher content of 8-structure than is found in the crystal structures (8-10) (-42% f-structure). We have noted a discrepancy in calculated P-structure by using another method of analysis (28) , but both methods suggest that FcRn and HLA-B40 have similar percentages of secondary structural elements.
Crystals of Soluble FcRn. Soluble FcRn protein forms crystals of approximate dimensions 0.3 mm x 0.1 mm x 0.1 mm in space group C2221 (Fig. 5) . The unit cell dimensions are a = 126.4 A, b = 191.7 A, and c = 149.6 A. The asymmetric unit of the crystal is estimated to contain two to four molecules based on average volume to mass ratios (Vm) of protein crystals (25) , representing solvent contents between 73% (if two molecules per asymmetric unit) to 32% (if four molecules per asymmetric unit). The crystals diffract to 3.5-A resolution using nickel-filtered CuKa radiation from a rotating-anode x-ray generator but suffer from radiation damage such that data can be collected only to 4-A resolution. The use of a synchrotron x-ray source (SSRL, Stanford University) greatly improves the resolution limit, and a complete native data set to 2.9-A resolution has been collected. Single crystals of a complex between FcRn and rat Fc Because the truncated p51 FcRn heavy chain was capable of being transported to the surface ofthe cell, and because little or no exchange of rat /32m with bovine or hamster P32m occurred, we next attempted to make a secreted form of FcRn. The gene encoding the truncated FcRn heavy chain was transfected together with the rat f32m gene, again using the Celltech glutamine synthetase-based amplifiable expression system. With this expression system, a high level of expression can be obtained after an initial selection, and gene amplification is rapidly achieved. Clones secreting soluble FcRn heterodimer were evaluated for relative expression levels by analysis of supernatant samples on Western blots, and a high-expressing clone secreting FcRn at 40 mg/liter was selected at 100 ILM MSX. FcRn was purified on a rat IgG affinity column by passing supernatants over the column at pH 6.5 and eluting protein at pH 8.0. This purification scheme is gentle, taking advantage of the physiological pH dependence of Fc binding, thereby avoiding the harsh elution conditions necessary for elution of immunoaffinity columns (27) .
SDS/PAGE analysis of purified FcRn showed two bands corresponding to truncated heavy chain and f2m. No evidence of covalent dimerization of the FcRn heavy chain mediated by a disulfide bond (1) was seen by comparison of the mobility under reducing and nonreducing conditions, and purified FcRn was eluted from a gel filtration column at the position expected for a complex of a single heavy and light chain (data not shown). Microsequencing of FcRn heterodimer revealed the expected N-terminal residues of the heavy chain and rat f32m in equimolar amounts, suggesting that f82m exchange either was minimal or did not occur. Because the structurally related class I MHC molecules are transported to the cell surface with peptides derived from intracellular proteins and appear to depend upon the presence of bound peptide for structural stability (4-7), we were interested to see whether FcRn heterodimers showed evidence of bound peptide. No other sequences were detectable, suggesting that the FcRn heterodimer was not complexed with a unique peptide. A mixture of peptides would probably not have been detected and cannot be ruled out as a possibility.
Samples of soluble FcRn and the human class I MHC molecule HLA-B40 were analyzed by CD spectroscopy (Fig.  4) . Analysis of CD spectra of the class I molecule was reasonably consistent with the known class I x-ray structures (8) (9) (10) and with previously reported CD spectra (22, 23) , suggesting that the molecule is primarily composed of (3-structure with a minor a-helical contribution. The CD spectrum of soluble FcRn appears similar, which together with the primary sequence similarity (2) further suggests that the two types of molecules may adopt similar tertiary structures. X-ray structural analysis of single crystals of soluble FcRn should ultimately allow the comparison of the two related molecules at atomic resolution and facilitate greater knowledge of the function of FcRn.
